digital diagnostic

Cognoa targets De Novo authorization for its autism diagnostic after reporting strong pivotal study results
By Dave Muoio | 10:45 am | September 23, 2020
The company said that its tool was "highly accurate" in a 425-participant study conducted across 14 U.S. sites.